Trulieve Cannabis (TCNNF) Equity Average (2020 - 2026)

Trulieve Cannabis' Equity Average history runs 7 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Equity Average fell 7.11% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 7.11% YoY), while the FY2025 annual figure was $1.2 billion, down 9.99% from the prior year.
• Equity Average was $1.1 billion for Q1 2026 at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $2.1 billion in Q1 2022 to a low of $1.1 billion in Q1 2026.
• Historically, Equity Average has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Equity Average soared 357.06% in 2022, then fell 29.73% in 2023.
• A 5-year view of Equity Average shows it stood at $2.0 billion in 2022, then retreated by 27.66% to $1.4 billion in 2023, then declined by 10.52% to $1.3 billion in 2024, then decreased by 8.64% to $1.2 billion in 2025, then slipped by 1.59% to $1.1 billion in 2026.
• The last three Equity Average figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.